Specialty pharmaceutical distributor simplifies, yet enhances user experience with intuitive web design
COLUMBIA, S.C., Nov. 18, 2015 /PRNewswire/ — BDI Pharma, Inc., the nation's fastest growing, independently owned specialty pharmaceutical distributor today announced the launch of its newly redesigned website at www.bdipharma.com. The new site offers an intuitive user interface seamlessly integrating product searches along with information gathering for the company's customized programs and solutions.
"The redesign was an extensive initiative involving both internal and external research and insight exercises," stated Brad Davis, AVP of Marketing. "Working with an agency of digital experts and user experience professionals, we developed an interface which has been optimized regardless of browser or platform to ensure that this resource remains an increasingly valuable asset to our customers, manufacturing partners and the many patients who frequent our site for information."
The new design brings customers improved search navigation for the numerous products BDI Pharma supplies. Items can be submitted through an order inquiry feature which instantaneously alerts the company's customer service department so that a representative can offer immediate assistance. The site also provides an extensive knowledge base of customized program offerings and clinical basics, each bringing added clarity to the otherwise complicated nature of specialty pharmaceuticals.
Additionally, the site was built with scalability, giving BDI Pharma an effective yet simple method to support their product portfolio expansion and solutions capabilities. This, along with in-depth metrics and reporting, will provide robust digital solutions to the company as well as beneficial insight to their manufacturing partners.
About BDI Pharma, Inc.
BDI Pharma creates customized solutions to meet the distribution and support needs of manufacturers, healthcare providers, and patients throughout the life of each product within the specialty, niche pharmaceutical market. We aspire towards financial viability for all parties involved, employ a partnership oriented approach, and drive value for our customers. We are continuously refining the concept of niche distribution to provide solutions beyond the traditional wholesaler model and operate as an extension of our partners' sales force, create demand, and move market share with each transaction. Our approach of serving the manufacturers as well as healthcare providers and patients over the last two decades has proven successful regardless of varying market conditions. This is further supplemented through innovative supply solutions, extensive product knowledge, 24/7 emergency availability and urgent need delivery. BDI Pharma's product portfolio includes IVIG, branded and generic specialty pharmaceuticals, chemotherapy, vaccines, albumin, coagulation factors, high-titer or "hyper" immune globulins, and other niche, specialty products. BDI Pharma is recognized as an "ADR," or Authorized Distributor of Record, for all of the manufacturers it represents.
Contact: Brad Davis
800-948-9834
Email